Socioeconomic Status and Healthcare Support on Anti-Tuberculosis Medication Adherence Among Pediatric Tuberculosis Patients

Main Article Content

Nissa Prima Sari

Abstract

Background: Tuberculosis (TB) remains a major public health challenge, particularly among children in low- and middle-income countries. Adherence to anti-tuberculosis (anti-TB) medication is essential for treatment success, but socioeconomic factors and healthcare support significantly influence adherence rates. This study examines the association between socioeconomic status (SES), healthcare support, and medication adherence among pediatric TB patients in Solok, West Sumatera, Indonesia. 


Methods: A cross-sectional study was conducted involving 57 pediatric TB patients. Data on SES, healthcare support, and medication adherence were collected through structured caregiver interviews and medical record reviews. Statistical analysis included Chi-square to identify factors influencing adherence.


Results: The study found that 73.7% of pediatric TB patients were adherent, while 26.3% were non-adherent. Children from higher SES backgrounds were 3.5 times more likely to adhere to treatment (OR = 3.5; 95% CI: 1.8–6.8, p = 0.003). Additionally, those receiving better healthcare support were 2.8 times more likely to adhere (OR = 2.8; 95% CI: 1.5–5.2, p = 0.041). 


Conclusion: Socioeconomic status and healthcare support significantly impact anti-TB medication adherence among pediatric patients. Strengthening health policies, financial support, and community-based healthcare programs can improve adherence rates and treatment outcomes. Public health strategies should focus on targeted interventions for low-income families to reduce treatment default rates. 

Article Details

How to Cite
1.
Sari NP. Socioeconomic Status and Healthcare Support on Anti-Tuberculosis Medication Adherence Among Pediatric Tuberculosis Patients. Front. Healthc. Res. [Internet]. 2025 Feb. 25 [cited 2025 May 20];2(1):30-6. Available from: https://frontiersonhealthcare.org/index.php/id/article/view/75
Section
Article

How to Cite

1.
Sari NP. Socioeconomic Status and Healthcare Support on Anti-Tuberculosis Medication Adherence Among Pediatric Tuberculosis Patients. Front. Healthc. Res. [Internet]. 2025 Feb. 25 [cited 2025 May 20];2(1):30-6. Available from: https://frontiersonhealthcare.org/index.php/id/article/view/75

References

World Health Organization (WHO). Global Tuberculosis Report; World Health Organization (WHO): Geneva, Switzerland, 2020.

World Health Organization. Global Tuberculosis Control: Epidemiology, Strategy, Financing: WHO Report 2009. World Health Organization; 2009.

Riccardi N, Alagna R, Motta I, et al. Towards ending TB: civil community engagement in a rural area of Senegal: results, challenges, and future proposal. Infect Dis. 2019;51(5):392–394.

Zegeye A, Dessie G, Wagnew F, et al. Prevalence, and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: a systematic review and meta-analysis. PLoS One. 2019;14(1):e0210422.

Lopez-Varela E, Sequera VG, García-Basteiro AL, et al. Adherence to childhood tuberculosis treatment in Mozambique. J Trop Pediatr. 2017;63(2):87–97.

Fagundez G, Perez-Freixo H, Eyene J, et al. Treatment adherence of tuberculosis patients attending two reference units in Equatorial Guinea. PLoS One. 2016;11(9):e0161995.

Gube AA, Debalkie M, Seid K, et al. Assessment of anti-TB drug nonadherence and associated factors among TB patients attending TB clinics in Arba Minch Governmental Health Institutions, Southern Ethiopia. Tuberc Res Treat. 2018;2018:1–7.

Castelnuovo B. Review of compliance to anti-tuberculosis treatment and risk factors for defaulting treatment in Sub Saharan Africa. Afr Health Sci. 2010;10(4).

Mekonnen HS, Azagew AW. Non-adherence to anti-tuberculosis treatment, reasons, and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia. BMC Res Notes. 2018;11(1):691.

Kebede A, Wabe NT. Medication adherence and its determinants among patients on concomitant tuberculosis and antiretroviral therapy in South West Ethiopia. N Am J Med Sci. 2012;4(2):67.

Woimo TT, Yimer WK, Bati T, Gesesew HA. The prevalence and factors associated for anti-tuberculosis treatment non-adherence among pulmonary tuberculosis patients in public health care facilities in South Ethiopia: a cross-sectional study. BMC Public Health. 2017;17(1):269.

Herrero MB, Ramos S, Arrossi S. Determinants of non-adherence to tuberculosis treatment in Argentina: barriers related to access to treatment. Rev Bras Epidemiol. 2015;18:287–298.

Gebreweld FH, Kifle MM, Gebremicheal FE, et al. Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study. J Health Popul Nutr. 2018;37(1):1.

Panuganti S, Bhavani K, Vijayasree L, Krishna A. A cross sectional study on factors influencing non-adherence to treatment among paediatric tuberculosis patients in field practice area of Osmania Medical College, Hyderabad. Int J Community Med Public Health. 2022; 9(6): 2479–2482.

Abdusalomova M, Denisiuk O, Davtyan H, Gadoev J, Abdusamatova B, Parpieva N, Sodikov A. Adverse Drug Reactions among Children with Tuberculosis in Tashkent, Uzbekistan, 2019. Int J Environ Res Public Health. 2021;18(14):7574.

Fekadu G, Bekele F, Bekele K, Girma T, Mosisa G, Gebre M, Alemu T, Tekle T, Gamachu B, Diriba A. Adherence to Anti-Tuberculosis Treatment Among Pediatric Patients at Nekemte Specialized Hospital, Western Ethiopia. Patient Prefer Adherence. 2020;14:1259-1265.

Carvalho ER, Rossoni AMO, Tahan TT, Rossoni MD, Rodrigues CO. Treatment regimens for tuberculosis in children and related adverse effects. Residencia Pediatrica. 2018; 8(1): 20-26.

Lolong DB, Aryastami NK, Kusrini I, Tobing KL, Tarigan I, Isfandari S, et al. Nonadherence to anti-tuberculosis treatment, reasons and associated factors among pulmonary tuberculosis patients in the communities in Indonesia. PLoS One. 2023;18(8):e0287628.

Rondags A, Himawan AB, Metsemakers JF, Kristina TN. Factors influencing non-adherence to tuberculosis treatment in Jepara, central Java, Indonesia. Southeast Asian J Trop Med Public Health. 2014 Jul;45(4):859-68.

Sazali MF, Rahim SSSA, Mohammad AH, Kadir F, Payus AO, Avoi R, et al. Improving Tuberculosis Medication Adherence: The Potential of Integrating Digital Technology and Health Belief Model. Tuberc Respir Dis (Seoul). 2023;86(2):82-93.

Leddy AM, Jaganath D, Triasih R, Wobudeya E, Bellotti de Oliveira MC, Sheremeta Y, et al. Social Determinants of Adherence to Treatment for Tuberculosis Infection and Disease Among Children, Adolescents, and Young Adults: A Narrative Review. J Pediatric Infect Dis Soc. 2022;11(Supplement_3):S79-S84.

Fekadu G, Bekele F, Bekele K, Girma T, Mosisa G, Gebre M, et al. Adherence to Anti-Tuberculosis Treatment Among Pediatric Patients at Nekemte Specialized Hospital, Western Ethiopia. Patient Prefer Adherence. 2020;14:1259-1265.

Nindrea RD, Laksmi NMDP, Yantri E, Hattori T, Masaki Y, Osaki K. Little Baby Handbook: Introducing Care for Small Babies in the Indonesian Community. Asia Pac J Public Health. 2023;35(8):592-593.

Nindrea RD. Impact of Telehealth on the Environment During the COVID-19 Pandemic in Indonesia. Asia Pac J Public Health. 2023;35(2-3):227.

Nindrea RD, Sari NP. How Does Family Planning Services Respond to the SARS-CoV-2 Pandemic in Indonesia? Asia Pac J Public Health. 2022;34(2-3):316-317.

Nindrea RD, Usman E, Katar Y, Darma IY, Warsiti, Hendriyani H, Sari NP. Dataset of Indonesian women's reproductive, high-fat diet and body mass index risk factors for breast cancer. Data Brief. 2021;36:107107.